ClinicalTrials.Veeva

Menu

Minimal Clinically Significant Difference (MCID) of Multidimensional Dyspnea Profile (MDP) in COPD Patients Undergoing Respiratory Rehabilitation (DYSCO)

A

Assistance Publique - Hôpitaux de Paris

Status

Not yet enrolling

Conditions

COPD

Treatments

Other: constant work-rate cycling exercise test

Study type

Interventional

Funder types

Other

Identifiers

NCT06012006
APHP221339

Details and patient eligibility

About

This study is designed to determine the individual threshold of minimal clinical change (MCID) for each component of the Multidimensional Dyspnea Profile (MDP) questionnaire in COPD patients undergoing pulmonary rehabilitation.

Full description

The aim of the research is to determine the minimal clinically significant difference (MCID) in MDP scores in COPD patients after a respiratory rehabilitation course using the anchoring method :

  • The A1 score will be compared with the Borg Affective Dyspnea (BorgA) scale.
  • The sensory score will be compared with the Borg Sensory Dyspnea Scale (BorgS).
  • The 5 sensory items will be compared with the Borg Sensory Dyspnea scale.
  • The emotional score will be compared with the Borg Emotional Dyspnea Scale.
  • The 5 emotional items will be compared with the Borg affective dyspnea scale. The various questionnaires will be administered to patients at inclusion, after a constant work-rate cycling exercise test, and at isotime during the same cycling exercise test at the end of the pulmonary rehabilitation course.

The sensitivity study will be conducted using the visual analog dyspnea scale instead of the Borg score. Finally, we will also determine the MCID using the distribution method. The MCID score will be correlated with various quality of life and physical performance scores.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gold B or D COPD patient
  • Moderate to severe obstructive ventilatory disorder (FEV1<80%)
  • Admitted for a pulmonary rehabilitation
  • Having given free, informed and written consent

Exclusion criteria

  • Lack of French language skills, preventing completion of questionnaires
  • Cognitive impairment preventing completion of questionnaires
  • Patient under guardianship
  • Patient not affiliated to the social security system
  • Chronic ethylism

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

120 participants in 1 patient group

pulmonary rehabilitation
Experimental group
Description:
COPD patients will be admitted for pulmonary rehabilitation, the duration and modalities of which vary from center to center.
Treatment:
Other: constant work-rate cycling exercise test

Trial contacts and locations

0

Loading...

Central trial contact

Capucine Morelot-Panzini, MD-PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems